A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

NCT07417306 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

912

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HDM1005 1
DRUG: HDM1005 2
DRUG: Mazdutide

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.